[Influence of ethnicity on the pharmacokinetics of amikacin]. 2013

Melisa Barrantes-González, and Santiago Grau, and David Conde-Estévez, and Esther Salas, and Mónica Marín-Casino
Melisa Barrantes-González, Departamento de Farmacia. Hospital del Mar. Universidad Autónoma de Barcelona. Passeig Marítim 25-29, 08003, Barcelona, Spain. melbarrantes@gmail.com.

OBJECTIVE Despite the increasing ethnic diversity, there are few studies of its influence on the pharmacokinetics of amikacin. The objective of this study was to compare the pharmacokinetics of amikacin in different populations: Asian, Hispanic, North Africans and Caucasian. METHODS A retrospective observational study was performed in a tertiary teaching hospital during eight years. It was included all patients with intravenous amikacin treatment in extended interval dosing regimen with therapeutic drug monitoring of amikacin. Pharmacokinetic parameters were analysed. A bivariate and multiple linear regression statistical analysis were carried out. RESULTS 164 patients were included: 7 asians, 135 Caucasians, 11 Hispanics and 11 from North Africa. It was shown a lower plasma concentrations of amikacin in North Africa population due to its greater clearance. CONCLUSIONS Amikacin plasma concentrations monitoring is advisable in patients from North Africa in order to avoid subtherapeutic concentrations.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003401 Creatine An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005006 Ethnicity A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships. Ethnic Groups,Nationality,Ethnic Group,Nationalities
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006630 Hispanic or Latino A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the-classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. Cuban Americans,Hispanic Americans,Latin Americans, US,Latinas,Latinos,Latinx,Puerto Ricans,Spanish Americans,Hispanics,American, Hispanic,American, US Latin,Cuban American,Hispanic American,Hispanic or Latinos,Latin American, US,Latina,Latino,Puerto Rican,Spanish American,US Latin American,US Latin Americans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Melisa Barrantes-González, and Santiago Grau, and David Conde-Estévez, and Esther Salas, and Mónica Marín-Casino
January 1980, International journal of clinical pharmacology, therapy, and toxicology,
Melisa Barrantes-González, and Santiago Grau, and David Conde-Estévez, and Esther Salas, and Mónica Marín-Casino
September 1989, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Melisa Barrantes-González, and Santiago Grau, and David Conde-Estévez, and Esther Salas, and Mónica Marín-Casino
April 1983, International journal of clinical pharmacology, therapy, and toxicology,
Melisa Barrantes-González, and Santiago Grau, and David Conde-Estévez, and Esther Salas, and Mónica Marín-Casino
January 1981, European journal of clinical pharmacology,
Melisa Barrantes-González, and Santiago Grau, and David Conde-Estévez, and Esther Salas, and Mónica Marín-Casino
December 1997, Journal of pharmaceutical sciences,
Melisa Barrantes-González, and Santiago Grau, and David Conde-Estévez, and Esther Salas, and Mónica Marín-Casino
October 1982, Pediatric research,
Melisa Barrantes-González, and Santiago Grau, and David Conde-Estévez, and Esther Salas, and Mónica Marín-Casino
February 2013, European review for medical and pharmacological sciences,
Melisa Barrantes-González, and Santiago Grau, and David Conde-Estévez, and Esther Salas, and Mónica Marín-Casino
March 1996, Antimicrobial agents and chemotherapy,
Melisa Barrantes-González, and Santiago Grau, and David Conde-Estévez, and Esther Salas, and Mónica Marín-Casino
April 1984, The Journal of antibiotics,
Melisa Barrantes-González, and Santiago Grau, and David Conde-Estévez, and Esther Salas, and Mónica Marín-Casino
February 1999, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!